Blog Archives

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

Certara2020 年 8 月 7 日

Blog

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

3 key tips to set your pediatric program up for success with the RACE for…

Certara2020 年 7 月 14 日

Blog

Local Therapies for the Global COVID-19 Pandemic

Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…

Certara2020 年 5 月 29 日

Blog

Applying decision analysis to drug development for COVID-19 & future pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions under…

Certara2020 年 4 月 30 日

Blog

Getting started with in-house development: 记事板制作

Introducing our three-part blog series on getting started with in-house development. In this series, we’re…

Certara2020 年 2 月 21 日

博客

Getting started with in-house development: how does it work?

Introducing our three-part blog series on getting started with in-house development. In this series, we’re…

Certara2020 年 2 月 10 日

Blog

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Model-based Meta-analysis is a framework to compare drugs used to treat diabetic peripheral neuropathy, post-herpetic…

Certara2019 年 12 月 19 日

Blog

Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates

Nirpal Virdee, Synchrogenix’s Global Head of Transparency and Disclosure recently sat down with Trishna Bharadia,…

Certara2019 年 11 月 11 日

Blog

ICER’s Unsupported Drug Price Increase Report: An Analysis

We analyze the drug-price watchdog, ICER’s (Institute for Clinical and Economic Review) “Report on Unsupported…

Certara2019 年 10 月 24 日

Blog

Health Canada PRCI Guiding Principles and Observations

Health Canada released guidance on 2019 年 3 月 12 日 pertaining to its Public Release of Clinical…

Certara2019 年 9 月 16 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

博客

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

The Research to Accelerate Cures and Equity (RACE) for Children Act: Changing the Landscape of Pediatric Cancer Drug Development

Local Therapies for the Global COVID-19 Pandemic

Applying decision analysis to drug development for COVID-19 & future pandemics

Getting started with in-house development: 记事板制作

Getting started with in-house development: how does it work?

Using Model-based Meta-analysis to Inform Neuropathic Pain Drug Development

Patient Engagement and Patient Centricity Series Part II: Types of Patient Advocates

ICER’s Unsupported Drug Price Increase Report: An Analysis

Health Canada PRCI Guiding Principles and Observations

订阅时事通讯

快捷链接

解决方案

联系我们